Application

PTO- 1478

Approved for use through 09/30/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

---

PTO- 1478

Approved for use through 09/30/2021. OMB 0651-0009

U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 97037986

Filing Date: 09/21/2021

To the Commissioner for Trademarks:

MARK: CIGNA PATHWELL SPECIALTY (Standard Characters, see mark)
The literal element of the mark consists of CIGNA PATHWELL SPECIALTY. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Cigna Intellectual Property, Inc., a corporation of Delaware, having an address of
      300 Bellevue Parkway
      Wilmington, Delaware 19809
      United States
      215-761-6221(phone)
      XXXX
Domiciled at: XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 035:  Cost management for the health benefit and prescription drug plans of others in the field of pharmaceuticals; business services, namely, cost management services for the prescription drug and medical formulary plans of others; consulting services regarding healthcare costs and retail pharmacy services; Drug utilization review services and drug and medical formulary management services; pharmaceutical and medical cost management services; in-network advisory services, strategic business analysis and business advice regarding pharmacy benefit management , medical benefit management, pharmaceutical end-user behavior, healthcare use behavior; market study and analysis of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level, providing business intelligence services in the field of pharmacy benefit management; administration of pharmacy benefit plans
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 036:  Pharmacy benefit management services. pharmacy benefit management consulting services; medical benefit management services; advisory services and consultancy regarding healthcare benefits , in-network coverage and pharmacy benefits; provision of information and analysis in the fields of healthcare plan benefits and pharmacy benefits; prescription coverage plans services, namely, providing insurance underwriting and claims administration of prescription drug plans for qualified beneficiaries; administration of pharmacy benefit plans; pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use and healthcare habits, and providing a predictive model to determine patients' future prescription drug and healthcare habits, all to identify potential cost savings and for clinical benefits
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

International Class 044:  Advisory services and consultancy regarding healthcare; healthcare services, namely, wellness and disease management programs for patients; prescription coverage plan services, namely, disease management programs and complex case management services in the nature of providing health consultation services to patients with chronic conditions regarding medication compliance, in-network services and providing information regarding health and safety issues regarding chronic conditions; providing medical information and analysis in the fields of healthcare, pharmaceuticals; providing information in the field of healthcare as provided to pharmacy benefit management services clients, consultants and brokers
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.


Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 4298899, 4298900, 2563544, and others.

The applicant's current Correspondence Information:

Cigna Intellectual Property, Inc.

PRIMARY EMAIL FOR CORRESPONDENCE: Troy.Larson@cigna.com        SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): cathy.early-warrington@cigna.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

A fee payment in the amount of $1050 has been submitted with the application, representing payment for 3 class(es).

Declaration

	Basis: If the applicant is filing the application based on use in commerce under 15 U.S.C. § 1051(a): The signatory believes that the applicant is the owner of the trademark/service mark sought to be registered; The mark is in use in commerce and was in use in commerce as of the filing date of the application on or in connection with the goods/services in the application; The specimen(s) shows the mark as used on or in connection with the goods/services in the application and was used on or in connection with the goods/services in the application as of the application filing date; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate. And/Or If the applicant is filing the application based on an intent to use the mark in commerce under 15 U.S.C. § 1051(b), § 1126(d), and/or § 1126(e): The signatory believes that the applicant is entitled to use the mark in commerce; The applicant has a bona fide intention to use the mark in commerce and had a bona fide intention to use the mark in commerce as of the application filing date on or in connection with the goods/services in the application; and To the best of the signatory's knowledge and belief, the facts recited in the application are accurate.
	To the best of the signatory's knowledge and belief, no other persons, except, if applicable, concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services of such other persons, to cause confusion or mistake, or to deceive.
	To the best of the signatory's knowledge, information, and belief, formed after an inquiry reasonable under the circumstances, the allegations and other factual contentions made above have evidentiary support.
	The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. § 1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any registration resulting therefrom, declares that all statements made of his/her own knowledge are true and all statements made on information and belief are believed to be true.

Declaration Signature

Signature: /Troy Larson/   Date: 09/21/2021
Signatory's Name: Troy Larson
Signatory's Position: Vice President, Cigna Intellectual Property, Inc.
Signatory's Phone Number: 215-761-6221
Signature method: Sent to third party for signature
Payment Sale Number: 97037986
Payment Accounting Date: 09/21/2021

Serial Number: 97037986
Internet Transmission Date: Tue Sep 21 16:15:23 ET 2021
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XX-20210921161523533
184-97037986-781a0319ae5b479c454d1274d5e
696a4c8a7c1313fb2367391f4f66ed65043674-D
A-15231669-20210921140542968048